Of course earnings are going to be the main driver, and even further down the track FDA approval, but as to a near term catalyst for some positive move I think inclusion into the ASX 300 could have the potential to be a pleasant surprise.
I'm pretty sure ASX 300 inclusion would make it available to a whole lot more funds than simply All Ords inclusion, and as I said due to the thin volume being traded, it wouldn't take very many newly interested parties to get it going in the right direction.
As to dropping 20% after All Ords inclusion. I think that's probably more to do with the fact that it happened smack bang in the middle of the major dowtrend/selldown since first approval back in Oct/Nov 2014. Knowing that there was someone there willing to sell off into any strength certainly wasn't helping sentiment towards the stock at the time.
Anyway I guess its all academic because as I said it may not even happen, but something else to maybe look forward to.
- Forums
- ASX - By Stock
- CUV
- Ann: SCENESSE launched in Europe-CUV.AX
Ann: SCENESSE launched in Europe-CUV.AX, page-13
Featured News
Add CUV (ASX) to my watchlist
|
|||||
Last
$14.80 |
Change
0.220(1.51%) |
Mkt cap ! $741.1M |
Open | High | Low | Value | Volume |
$14.61 | $14.99 | $14.40 | $1.156M | 78.91K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 478 | $15.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.32 | 51 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 426 | 15.540 |
2 | 190 | 15.240 |
1 | 143 | 15.130 |
1 | 1044 | 15.090 |
3 | 769 | 14.900 |
Price($) | Vol. | No. |
---|---|---|
14.060 | 475 | 3 |
14.360 | 622 | 5 |
14.530 | 166 | 1 |
14.800 | 460 | 1 |
14.830 | 1000 | 1 |
Last trade - 15.59pm 10/07/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online